Scientific Advisory Board
The OncoFirm Diagnostics Advisory Boards are composed of leading experts in oncology, molecular diagnostics, regulatory affairs, clinical medicine, and biotechnology commercialization. This distinguished group provides strategic guidance and scientific oversight as we advance the development and global deployment of our rapid cancer screening technologies.
Our advisors bring deep experience from academia, healthcare systems, diagnostic innovation, and public health policy—ensuring that our products are clinically relevant, regulatory-ready, and impactful across diverse healthcare settings. With their insights, we are driving innovation that empowers early cancer detection and improves outcomes for patients worldwide.
Watch our team coming together!
Matthew Koslow, PhD Dr. Matthew Koslow is a molecular and cellular biologist with experience spanning oncology, drug discovery, molecular biology, translational research, and preclinical development. He brings a multidisciplinary scientific…
Ting-Wen Lo, PhD Dr. Ting-Wen Lo is a biomedical researcher and chemical engineer with extensive experience in microfluidics, in vitro diagnostic technologies, biomarker analysis, molecular biology, and the development of…
Dejun (DJ) Tang, PhD Lead Medical Advisor & Director of Statistics Dr. Dejun “DJ” Tang serves as Lead Medical Advisor at OncoFirm™ Diagnostics, bringing more than 27 years of pharmaceutical,…
Researchers – Fluorescent Lateral Flow Markers Company: OncoFirm™ Diagnostics CorporationDepartment: Research & Development / Assay DevelopmentPosition Type: Research / Scientific Collaboration / Contract or Grant-SupportedField: Fluorescent Lateral Flow Immunoassays, Biomarkers,…